Lv4
580 积分 2024-10-18 加入
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled, double-blind, phase III clinical trials
4小时前
已完结
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
2个月前
已完结
Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic
2个月前
已完结
Tackling hepatitis B Virus with CRISPR/Cas9: advances, challenges, and delivery strategies
3个月前
已完结
A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally-suppressed, HBeAg negative chronic hepatitis B patients
3个月前
已完结
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
3个月前
已完结
Combination Therapy for Chronic HBV Infection
3个月前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
3个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
3个月前
已完结
Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions
4个月前
已完结
皖公网安备34019202002308
